Endoscopic screening for gastric cancer: A cost-utility analysis for countries with an intermediate gastric cancer risk

United European Gastroenterology Journal

Volumn 6, Issue 2, 2018, Pages 192-202

  Areia, Miguel ^a,b   Spaander, Manon C W ^c   Kuipers, Ernst J ^c   Dinis Ribeiro, Mário ^a,d  

^a University of Porto   (Portugal)

^b Instituto Portugues de Oncologia Francisco Gentil Centro Regional de Oncologia de Coimbra SA   (Portugal)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

Author keywords

costs and cost analysis; early detection of cancer; gastrointestinal endoscopy; Markov chains; Stomach neoplasm

Indexed keywords

PEPSINOGEN;

ADULT; AGED; BLOOD SAMPLING; CANCER RISK; CANCER SCREENING; COST UTILITY ANALYSIS; FEMALE; GASTROSCOPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OCCULT BLOOD; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE QUESTIONNAIRE; QUESTIONNAIRE; REVIEW; STOMACH CANCER;

EID: 85042528625     PISSN: 20506406     EISSN: 20506414     Source Type: Journal    
DOI: 10.1177/2050640617722902     Document Type: Review

References (35)

1. Torre LA, Bray F, Siegel RL, Global cancer statistics, 2012. CA Cancer J Clin 2015; 65: 87–108.
2. Areia M, Pimentel-Nunes P, Marcos-Pinto R, Gastric cancer: An opportunity for prevention. Acta Med Port 2013; 26: 627–629.
3. Ferlay J, Soerjomataram I, Ervik M, et al. Cancer incidence and mortality worldwide: IARC CancerBase No. 11. GLOBOCAN 2012 v10. Lyon, France: International Agency for Research on Cancer, 2013
4. Zhou L, Guan P, Sun LP, Health economic assessment for screening of gastric cancer in a high risk population in northeastern China. Chin J Cancer Res 2011; 23: 21–24.
5. Pimentel-Nunes P, Mourao F, Veloso N, Long-term follow-up after endoscopic resection of gastric superficial neoplastic lesions in Portugal. Endoscopy 2014; 46: 933–940.
6. Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon T, Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2015; 47: 829–854.
7. Yeh JM, Hur C, Ward Z, Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: A cost-effectiveness analysis. Gut 2016; 65: 563–574.
8. Dinis-Ribeiro M, Areia M, de Vries AC, Management of precancerous conditions and lesions in the stomach (MAPS): Guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012; 44: 74–94.
9. Areia M, Dinis-Ribeiro M, Rocha Gonçalves F. Cost-utility analysis of endoscopic surveillance of patients with gastric premalignant conditions. Helicobacter 2014; 19: 425–436.
10. Marques-Silva L, Areia M, Elvas L, Prevalence of gastric precancerous conditions: A systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2014; 26: 378–387.
11. von Karsa L, Patnick J, Segnan N. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition – Executive summary. Endoscopy 2012; 44(Suppl 3): SE1–SE8.
12. Hassan C, Quintero E, Dumonceau JM, Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2013; 45: 842–851.
13. Quintero E, Castells A, Bujanda L, Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 2012; 366: 697–706.
14. Dinis-Ribeiro M, Yamaki G, Miki K, Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. J Med Screen 2004; 11: 141–147.
15. Lomba-Viana R, Dinis-Ribeiro M, Fonseca F, Serum pepsinogen test for early detection of gastric cancer in a European country. Eur J Gastroenterol Hepatol 2012; 24: 37–41.
16. Russell LB, Gold MR, Siegel JE, The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996; 276: 1172–1177.
17. Husereau D, Drummond M, Petrou S, Consolidated Health Economic Evaluation Reporting Standards (CHEERS) – explanation and elaboration: A report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health 2013; 16: 231–250.
18. Areia M, Carvalho R, Cadime AT, Screening for gastric cancer and surveillance of premalignant lesions: A systematic review of cost-effectiveness studies. Helicobacter 2013; 18: 325–337.
19. Pordata. Lisbon: Francisco Manuel dos Santos Foundation, 2013
20. Areia M, Alves S, Brito D, Health-related quality of life and utilities in gastric premalignant conditions and malignant lesions: A multicentre study in a high prevalence country. J Gastrointestin Liver Dis 2014; 23: 371–378.
21. Whiting JL, Sigurdsson A, Rowlands DC, The long term results of endoscopic surveillance of premalignant gastric lesions. Gut 2002; 50: 378–381.
22. Choi KS, Suh M. Screening for gastric cancer: The usefulness of endoscopy. Clin Endosc 2014; 47: 490–496.
23. Hassan C, Zullo A, Di Giulio E, Cost-effectiveness of endoscopic surveillance for gastric intestinal metaplasia. Helicobacter 2010; 15: 221–226.
24. Zhou HJ, Dan YY, Naidoo N, A cost-effectiveness analysis evaluating endoscopic surveillance for gastric cancer for populations with low to intermediate risk. PLoS One 2013; 8: e83959–e83959.
25. Ogoshi K, Narisawa R, Kato T, Endoscopic screening for gastric cancer in Niigata city [article in Japanese]. Jpn J Endoscopic Forum Digestive Disease 2010; 26: 5–16.
26. Lee YY, Oh DK, Choi KS, The current status of gastric cancer screening in Korea: Report on the National Cancer Screening Programme, 2009. Asian Pac J Cancer Prev 2011; 12: 3495–3500.
27. National Cancer Center: Cancer Facts & Figures 2014. Goyang: National Cancer Center, 2014, p.124
28. Kwon YM, Lim HT, Lee K, Factors associated with use of gastric cancer screening services in Korea. World J Gastroenterol 2009; 15: 3653–3659.
29. Sachs JD. Macroeconomics and health: Investing in health for economic development, Geneva: World Health Organization, 2001.
30. Tashiro A, Sano M, Kinameri K, Comparing mass screening techniques for gastric cancer in Japan. World J Gastroenterol 2006; 12: 4873–4874.
31. Lee HY, Park EC, Jun JK, Comparing upper gastrointestinal X-ray and endoscopy for gastric cancer diagnosis in Korea. World J Gastroenterol 2010; 16: 245–250.
32. Chang HS, Park EC, Chung W, Comparing endoscopy and upper gastrointestinal X-ray for gastric cancer screening in South Korea: A cost-utility analysis. Asian Pac J Cancer Prev 2012; 13: 2721–2728.
33. Dan YY, So JB, Yeoh KG. Endoscopic screening for gastric cancer. Clin Gastroenterol Hepatol 2006; 4: 709–716.
34. Wu JT, Zhou J, Naidoo N, Determining the cost-effectiveness of endoscopic surveillance for gastric cancer in patients with precancerous lesions. Asia Pac J Clin Oncol 2016; 12: 359–368.
35. Gupta N, Bansal A, Wani SB, Endoscopy for upper GI cancer screening in the general population: A cost-utility analysis. Gastrointest Endosc 2011; 74: 610–624.